FDA Has Known about Vaccine Shedding for Years and Has Even Issued Guidance on How to Evaluate the Risk

Rhoda Wilson

In 2015 the US Food and Drug Administration (“FDA”) issued guidance on how to conduct shedding studies during the preclinical and clinical development of virus or bacteria-based gene therapy products. Shedding, as described by the FDA, is the excretion or release of a product from a vaccinated person’s body. The shed gene therapy product may be infectious and so raises safety concerns “related to the risk of transmission to untreated individuals.”

Various studies and documents, including a study by Pfizer, indicate vaccine shedding and transmission are occurring.

A University of Colorado study published in May provided evidence “for a new mechanism by which herd immunity may be manifested – the aerosol transfer of antibodies between immune and non-immune hosts.”

… Additionally, in February 2022, Dr. Philippe van Welbergen demonstrated that “shards” of graphene are being transmitted from vaccinated to unvaccinated people.

Latest articles

Bruce Scott In Part I of Menticide 101 and the Brainwashing of...
Bruce Scott It has become quite clear, especially during the last two...
Joseph Mercola Scientists warn repeated COVID boosters may result in lowered immunity...
Mitchell Brent Liester Chlorine dioxide has been condemned as a dangerous poison...
Paul Elkins The recent White House guidance for people to take the...
Igor Chudov The times are changing! Remember how we said that vaccine shedding...

Your donation helps us
stand up for health freedom!

Canada Health Alliance is volunteer run and 100% supported by the generous donations of those who share our concerns and value our work.

Thank you!

The form has been submitted successfully!